Volume Kinetics for Starch Solution and Acetated Ringers
NCT01195025 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2014-10-22
Summary
Volume kinetics is a method mostly used, so far, to study the distribution and elimination of crystalloid solutions. Voluven (in Sweden the most commonly used colloid for replacement of bleeding during surgery) is poorly studied, though. Also, a recent study showed unexpected volume kinetics for a crystalloid solution when it was given after a colloid solution. The investigators aim to study the volume kinetics of crystalloids and colloids and also the combination of the two in more detail. The investigators will also compare the invasive hemoglobin measurements with measurements from a new non-invasive tool (Radical 7, from Masimo Inc.) which could help to make volume kinetics more practical for everyday use. Finally the investigators will also study the concentrations of a few coagulation factors to see if they can explain the variations in coagulability that has been described in earlier studies of infusion solutions.
Conditions
- Blood Volume
- Blood Coagulation
Interventions
- DRUG
-
acetated Ringers
Infusion of Ringer acetate 20 ml/kg over 30 min
- DRUG
-
colloid
Infusion of starch 10 ml/kg over 30 min
- DRUG
-
colloid+acetated Ringer
Infusion of combined colloid+acetated Ringer; 10 ml/kg of starch was infused between 0 and 30 min, followed by 20 ml/kg of Ringers acetate between 105 and 135 min.
- DEVICE
-
Non-invasive hemoglobin with pulse-oximeter (SpHb)
Non-invasive hemoglobin with pulse-oximeter (SpHb) was measured in all subjects, during all infusions.
Sponsors & Collaborators
-
University Hospital, Linkoeping
lead OTHER
Principal Investigators
-
Joachim Zdolsek, MD, PhD · University Hospital, Linköping, Sweden
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-08-31
- Primary Completion
- 2011-05-31
- Completion
- 2011-05-31
Countries
- Sweden
Study Locations
More Related Trials
-
Platelets or Fibrinogen as First-line Treatment for Bleeding During Pedatric Heart Surgery
NCT04807621 ·Status: UNKNOWN ·Phase: PHASE2
-
Patient Blood Management for Massive Obstetric Hemorrhage
NCT03784794 ·Status: COMPLETED ·Phase: NA
-
Effect of Colloid Versus Crystalloid on Coagulation in Elective Urological Surgery
NCT02009033 ·Status: COMPLETED ·Phase: PHASE4
-
Control of Major Bleeding After Trauma Study
NCT01838863 ·Status: TERMINATED ·Phase: PHASE2
-
Early Use of Cryoprecipitate With Major Hemorrhage Protocol (MHP) Activation
NCT04704869 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Balanced Crystalloid and Colloid Infusion on Haemostasis in Healthy Male Volunteers
NCT05148650 ·Status: UNKNOWN ·Phase: NA
-
In Vivo Effects of Fibrinogen Concentrate (FC) Versus Cryoprecipitate on the Neonatal Fibrin Network Structure After Cardiopulmonary Bypass (CPB)
NCT03932240 ·Status: COMPLETED ·Phase: PHASE3
-
Calculating Blood Volume by Dilution of Hemoglobin - Pilot Study
NCT01900769 ·Status: COMPLETED ·Phase: NA
-
Pre-hospital Administration of Fibrinogen in Trauma-Induced Coagulopathy
NCT06582420 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Massive Transfusion Protocol With Coagulation Algorithm
NCT02350101 ·Status: COMPLETED
-
Comparison of Fibrinogen Concentrate and Cryoprecipitate in Pediatric Cardiac Surgery Patients
NCT04376762 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial of a Hospital Policy of Tranexamic Acid Use to Reduce Transfusion in Major Non-cardiac Surgery
NCT04803747 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy of the Administration of Fibrinogen in Liver Transplantation
NCT01539057 ·Status: UNKNOWN ·Phase: PHASE3
-
Impact of Topical Tranexamic Acid on Pre- and Post-operative Hemoglobin/Hematocrit
NCT05357079 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Comparison of Aprotinin and Tranexamic Acid in Routine Cardiac Surgery
NCT00396760 ·Status: UNKNOWN ·Phase: PHASE3
-
The Transfusion Triggers in Vascular Surgery Trial
NCT02465125 ·Status: COMPLETED ·Phase: PHASE2
-
Fibrinogen Concentrate vs Cryoprecipitate
NCT03014700 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect on Blood Loss of Topical and Intravenous Tranexamic Acid in Cardiac Surgery Patients
NCT01895101 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Colloid Versus Crystalloid on Coagulation
NCT01444508 ·Status: UNKNOWN ·Phase: PHASE4
-
Tranexamic Acid and Blood Clots in Knee Surgery
NCT02867163 ·Status: COMPLETED
-
Blood Products Transfusion in Cardiac Surgery After the Implementation of a Coagulation Monitoring System at Patient Bedside: Thromboelastometry Versus Standard Transfusion Protocol
NCT01919840 ·Status: TERMINATED ·Phase: PHASE4
-
Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage at Pre-hospital Phase of Care.
NCT03780894 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Fibrinogen Concentrate (FGTW) in Trauma Patients, Presumed to Bleed (FI in TIC)
NCT01475344 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Retrograde Autologous Priming and Mannitol for Reducing Hemodilution in Cardiac Surgery
NCT04870073 ·Status: WITHDRAWN ·Phase: PHASE3
-
Use of Blood and Plasma in Norwegian Physician-staffed Helicopter Emergency Medical System
NCT02784951 ·Status: COMPLETED